Digestive tract stent with anti-cancer medicinal particles

Abstract

A scaffold of the granular anticancer medicine for treating the benign or malignant stenosis of esophagus and digestive tract is disclosed, which has 4 structures consisting of scaffold, granular anticancer medicine, selective coated film on the surface of scaffold, and selective external protective layer.

Description

technical field

[0001] The invention relates to a component in the technical field of medicine and medical equipment, in particular to a digestive tract bracket for anticancer drug particles. Background technique

[0002] Gastrointestinal benign and malignant strictures are clinically common diseases. Among them, malignant stenosis of the digestive tract caused by malignant tumors of the esophagus, stomach, intestinal tract, and biliary tract is a high-incidence disease in patients with digestive tract cancer. In addition to surgical resection, radiotherapy and chemotherapy, commonly used interventional methods mainly include balloon dilatation (mainly for benign strictures) and stent placement. For patients with advanced digestive tract cancer, stent implantation is a very important palliative treatment method, which can effectively improve the quality of life and prolong the survival time of patients with advanced digestive tract cancer. However, traditional metal stents...

Examples

Embodiment 1

[0045]Such as figure 1 and figure 2 As shown, the present invention includes: a stent 1 , anticancer drug particles 3 , and the anticancer drug particles 3 are directly carried on the stent 1 .

[0046] The anticancer drug particles 3 are implanted dosage forms, the carrier material used is glycolide / lactide copolymer, and the anticancer drug is 5-fluorouracil. The anticancer drug particles 3 are tied to the alloy wire of the stent 1 through surgical sutures.

[0047] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant esophageal tumors. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatment of strictures caused by malignancy of the esophagus.

Embodiment 2

[0049] Such as image 3 and Figure 4 As shown, the present invention includes: a stent 1, a coating 2 and anticancer drug particles 3, the coating 2 is wrapped on the surface of the stent 1, the coating 2 is close to the stent 1, and the anticancer drug particles 3 are carried on the coating 2 Above, the protective layer 4 is set on the anticancer drug particle 3 layer.

[0050] The material of the envelope 2 is polyurethane.

[0051] The anticancer drug particles 3 are microspheres, the carrier material is starch, and the antitumor drug is cisplatin. Anticancer drug particles adhere to the envelope 2 through acrylic pressure-sensitive adhesive.

[0052] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant esophageal tumors. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatmen...

Embodiment 3

[0054] Such as Figure 5 and Figure 6 As shown, the present invention includes: a stent 1 , anticancer drug particles 3 , and a protective layer 4 , and the anticancer drug particles 3 are directly carried on the stent 1 . The protective layer 4 is set on the anticancer drug particle 3 layer.

[0055] The anticancer drug particles 3 are nanospheres, the carrier material is albumin, and the antitumor drug is hydroxycamptothecin. The anticancer drug particles 3 are directly bonded to the wire of the stent 1 through a medical adhesive.

[0056] The protective layer 4 is a water-soluble film of polyvinylpyrrolidone.

[0057] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant tumors of the biliary tract. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatment of strictures caused b...

technical field

[0001] The invention relates to a component in the technical field of medicine and medical equipment, in particular to a digestive tract bracket for anticancer drug particles. Background technique

[0002] Gastrointestinal benign and malignant strictures are clinically common diseases. Among them, malignant stenosis of the digestive tract caused by malignant tumors of the esophagus, stomach, intestinal tract, and biliary tract is a high-incidence disease in patients with digestive tract cancer. In addition to surgical resection, radiotherapy and chemotherapy, commonly used interventional methods mainly include balloon dilatation (mainly for benign strictures) and stent placement. For patients with advanced digestive tract cancer, stent implantation is a very important palliative treatment method, which can effectively improve the quality of life and prolong the survival time of patients with advanced digestive tract cancer. However, traditional metal stents...

Examples

Embodiment 1

[0045]Such as figure 1 and figure 2 As shown, the present invention includes: a stent 1 , anticancer drug particles 3 , and the anticancer drug particles 3 are directly carried on the stent 1 .

[0046] The anticancer drug particles 3 are implanted dosage forms, the carrier material used is glycolide / lactide copolymer, and the anticancer drug is 5-fluorouracil. The anticancer drug particles 3 are tied to the alloy wire of the stent 1 through surgical sutures.

[0047] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant esophageal tumors. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatment of strictures caused by malignancy of the esophagus.

Embodiment 2

[0049] Such as image 3 and Figure 4 As shown, the present invention includes: a stent 1, a coating 2 and anticancer drug particles 3, the coating 2 is wrapped on the surface of the stent 1, the coating 2 is close to the stent 1, and the anticancer drug particles 3 are carried on the coating 2 Above, the protective layer 4 is set on the anticancer drug particle 3 layer.

[0050] The material of the envelope 2 is polyurethane.

[0051] The anticancer drug particles 3 are microspheres, the carrier material is starch, and the antitumor drug is cisplatin. Anticancer drug particles adhere to the envelope 2 through acrylic pressure-sensitive adhesive.

[0052] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant esophageal tumors. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatmen...

Embodiment 3

[0054] Such as Figure 5 and Figure 6 As shown, the present invention includes: a stent 1 , anticancer drug particles 3 , and a protective layer 4 , and the anticancer drug particles 3 are directly carried on the stent 1 . The protective layer 4 is set on the anticancer drug particle 3 layer.

[0055] The anticancer drug particles 3 are nanospheres, the carrier material is albumin, and the antitumor drug is hydroxycamptothecin. The anticancer drug particles 3 are directly bonded to the wire of the stent 1 through a medical adhesive.

[0056] The protective layer 4 is a water-soluble film of polyvinylpyrrolidone.

[0057] The stent prepared by the present invention is used for the treatment of stenosis caused by malignant tumors of the biliary tract. It not only has a mechanical expansion effect, but also can directly act on the diseased tissue or its vicinity with the released drug, so as to perform local slow and long-term administration. Treatment of strictures caused b...

Images